Table 2. Shows comparison of survivors to non-survivors with COVID19 using T-test for continuous variables and Chi-square statistical analysis for categorical variables.
Variable | Survivor (65) | Non survivor (11) | P |
---|---|---|---|
Age | 54.9±13.6 | 65.7±2.9 | 0.005 |
Gender: | |||
Male | 46 | 10 | 0.161 |
Female | 19 | 1 | |
Diabetes | 43 (67.1) | 5 (45.4) | 0.188 |
hypertension | 64 (98.4) | 11 (100) | 0.679 |
Nationality: | |||
Citizens | 18 (27.6) | 2 (18.1) | 0.508 |
Expatriates | 47 (72.3) | 9 (81.8) | |
Ischemic Heart Disease | 14 (21.5) | 5 (45.4) | 0.09 |
Congestive Heart Failure | 1 (1.5) | 1 (9.0) | 0.148 |
COPD | 1 (1.5) | 1 (8.0) | 0.148 |
Atrial Fibrillation | 4 (6.15) | 4 (36.3) | 0.03 |
Bronchial Asthma | 5 (7.69) | 2 (18.1) | 0.266 |
History of deep venous thrombosis | 2 (3.0) | 2 (18.1) | 0.038 |
Received Flu Vaccine | 42(64.6) | 10 (90.9) | 0.083 |
Received pneumococcal vaccine | 51 (78.4) | 7 (63.6) | 0.285 |
Dialysis Modality: | |||
Hemodialysis | 55 (84.6) | 10 (90.9) | 0.5 |
Peritoneal dialysis | 10 (65.0) | 1 (9.0) | |
Dialysis Access: | |||
Central venous catheter | 18 (27.7) | 6 (54.5) | 0.048 |
Arteriovenous fistula | 35 (53.8) | 4 (36.3) | |
Arteriovenous graft | 2 (3.0) | 0 (0) | |
Peritoneal dialysis | 10 (15.3) | 1(9) | |
History of kidney transplant | 3 (4.6) | 1 (9.0) | 0.539 |
Steroid | 1 (1.5) | 1 (9.0) | 0.148 |
Symptoms at diagnosis: | |||
SOB | 1 | 1 | 0.195 |
Fever | 38 | 6 | 0.970 |
Cough | 34 | 9 | 0.028 |
Sore throat | 7 | 1 | 0.350 |
Myalgia | 1 | 0 | 0.326 |
Body pain | 4 | 0 | 0.257 |
Vomiting | 6 | 1 | 0.350 |
Diarrhea | 6 | 1 | 0.950 |
Hypoxia | 9 (13.8) | 9 (81.8) | <0.001 |
Admission to ICU | 10(15) | 10(90) | <0.0001 |
Mechanical ventilation | 4(6) | 10(90) | <0.0001 |
Inotropes | 1(2) | 10(90) | <0.0001 |
Chest x ray: | 0.05 | ||
Normal | 21 (32.3) | 0 (0) | |
Unilateral | 9 (13.8) | 1 (9.0) | |
Bilateral | 35 (53.8) | 10 (90.9) | |
WBC base | 6.7±2.8 | 6.0±3.1 | 0.598 |
WBC after 7 days | 6.2±4.1 | 9±4.5 | 0.269 |
WBC peak | 9.9±7.6 | 21.9±10 | 0.058 |
Lymphocytes base | 1.2±0.63 | 0.88±0.65 | 0.945 |
Lymphocytes after 7 days | 1.07±0.76 | 0.58±0.25 | 0.019 |
HB base | 11.5±1.6 | 11.3±1.7 | 0.583 |
HB after 7 days | 10.1±3.2 | 10.7±2.0 | 0.656 |
PLT base | 221.1±262 | 164±86.2 | 0.787 |
PLT after 7 days | 207.8±103.9 | 149.9±96.7 | 0.497 |
PT base | 6.9±7.2 | 18.2±11.9 | 0.218 |
PT after 7 days | 7.3±13.8 | 20.4±11.8 | 0.616 |
PTT base | 19.3±19.0 | 38.6±10.0 | <0.001 |
PTT after 7 days | 13.7±17.2 | 47.6±25.3 | 0.466 |
INR base | 0.59±0.61 | 1.5±0.99 | 0.172 |
INR after 7 days | 0.54±1.0 | 1.7±0.99 | 0.388 |
Ferritin base | 1188.4±230.1 | 4774.4±9357.3 | <0.001 |
Ferritin after 7 days | 1492.5±2865.1 | 11923.5±20982 | <0.001 |
Ferritin Peak | 2469.4±4792.7 | 23575±22875.1 | <0.001 |
Fibrinogen base | 1.83±6.0 | 3.2±2.2 | 0.597 |
Fibrinogen after 7 days | 1.3±2.4 | 3.8±2.2 | 0.422 |
CRP base | 41.6±63.6 | 77.2±83.4 | 0.192 |
CRP after 7 days | 45.6±68.3 | 113.4±85.9 | 0.214 |
CRP peak | 74.5±94.5 | 477.1±871.2 | <0.001 |
CPK base | 126.1±516.4 | 883.1±1699.9 | <0.001 |
CPK after 7 days | 15.4±43.1 | 632±1849.4 | <0.001 |
LDH base | 136.5±169.8 | 424.1±365.3 | 0.025 |
LDH after 7 days | 106.5±194.2 | 374.2±286.3 | 0.054 |
D-Dimer base | 0.797±1.23 | 12.0±18.8 | <0.001 |
D-Dimer after 7 days | 0.569±0.90 | 3.0±2.2 | <0.001 |
Lactate base | 0.42±0.68 | 1.2±1.8 | <0.001 |
Lactate after 7 days | 1.5±4.9 | 0.38±0.67 | 0.086 |
ALT base | 20.6±15.0 | 40.1±50.9 | <0.001 |
ALT after 7 days | 20.7±14.2 | 251±709 | <0.001 |
AST base | 24.7±15.7 | 77.3±83.5 | <0.001 |
AST after 7 days | 25.1±18.4 | 696.2±2091 | <0.001 |
IL-6 Base | 16.7±40.9 | 340.2±918.7 | 0.001 |
IL-6 after 7 days | 57.6±350.7 | 66.8±132.9 | 0.952 |
IL-6 Peak | 460.7±2056 | 3270±5240 | <0.001 |
O2 saturation base | 95.7±8.1 | 93.6±18.4 | 0.533 |
O2 saturation after 7 days | 94.0±8.4 | 93.4±4.3 | 0.977 |
Albumin base | 32.6±6.7 | 24.4±11.4 | 0.091 |
Albumin after 7 days | 27.6±16.1 | 23.5±5.5 | 0.790 |